US20080021114A1 - Compositions and Methods for the Prevention and Treatment of Diseases in Plants - Google Patents

Compositions and Methods for the Prevention and Treatment of Diseases in Plants Download PDF

Info

Publication number
US20080021114A1
US20080021114A1 US11/535,737 US53573706A US2008021114A1 US 20080021114 A1 US20080021114 A1 US 20080021114A1 US 53573706 A US53573706 A US 53573706A US 2008021114 A1 US2008021114 A1 US 2008021114A1
Authority
US
United States
Prior art keywords
composition
wax
compositions
present
emulsifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/535,737
Inventor
Paul Winniczuk
Emery Ellinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Preservation Sciences Inc
Original Assignee
Preservation Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Preservation Sciences Inc filed Critical Preservation Sciences Inc
Priority to US11/535,737 priority Critical patent/US20080021114A1/en
Publication of US20080021114A1 publication Critical patent/US20080021114A1/en
Assigned to HYMAN, LARRY S. reassignment HYMAN, LARRY S. COURT ORDER Assignors: PRESERVATION SCIENCES, INC.
Assigned to TRANSFER TECHNOLOGIES INTERNATIONAL CORPORATION reassignment TRANSFER TECHNOLOGIES INTERNATIONAL CORPORATION PURCHASE AGREEMENT Assignors: SB INVESTMENT TRUST
Assigned to SB INVESTMENT TRUST reassignment SB INVESTMENT TRUST COURT ORDER Assignors: HYMAN, LARRY S.
Assigned to PRESERVATION SCIENCES, INC. reassignment PRESERVATION SCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ELLINGER, EMERY
Assigned to PRESERVATION SCIENCES, INC. reassignment PRESERVATION SCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WINNICZUK, PAUL
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N27/00Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons

Definitions

  • the present invention relates to compositions and methods for the treatment and prevention of bacterial and fungal disease in plants.
  • the important diseases which can be treated and prevented by such compositions and methods is citrus canker.
  • citrus canker alone causes severe economic consequences in the world's citrus growing regions.
  • the bacteria which causes citrus canker, Xanthomonas campestris pv. citri has been found in southern Asia, Japan, the Middle East, Africa, South America and now North America. Historically, citrus canker outbreaks have occurred in North America in the early 1900s and again in 1986. Fortunately, through the use of aggressive eradication techniques, the disease was eliminated in both instances.
  • Citrus canker can be reintroduced when people inadvertantly transport infected citrus fruits and seedlings into citrus growing areas in the U.S. and elsewhere.
  • Florida In the U.S., Florida is by far the state most at risk from citrus canker given its combination of high humidity throughout the year, seasonal hurricanes and frequent thunderstorms accompanied by high wind gusts. (See The University of Florida Plant Pathology Department Report at vvvvw.biotech.ufl.edu/PlantContainment/canker.htm.)
  • Costs in managing the threat of citrus canker include capital investment for spray equipment, the lost value of affected fruit, costs associated with inspection and eradication, and costs associated with the creation of natural windbreaks and other defensive tactics.
  • Current spraying programs include relatively expensive copper based sprays. The University of Florida Extension Service has estimated that if citrus canker became endemic in Florida, the total cost for countering endemic citrus canker, including the use of copper based sprays, could be more than $300 per acre.
  • the present invention provides non-toxic, environmentally friendly, effective and economical compositions and methods which prevent and treat bacterial and fungal disease in plants. More particularly, the present invention is effective in preventing and treating disease caused by the various species of the bacteria Xanthomonas , including diseases such as citrus canker.
  • Compositions according to the present invention include d-limonene as the primary active ingredient alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients. Applicants have unexpectedly found that such compositions are capable of preventing and treating bacterial and fungal disease in plants, including citrus canker.
  • compositions and methods according to the present invention are environmentally friendly since they do not include or involve the use of toxic chemicals or chemicals at toxic levels. Accordingly, there are minimal regulatory limitations for the use of such compositions.
  • the present invention also provides methods of making and using such compositions.
  • one object of the present invention is to provide compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker, comprising d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and/or other ingredients.
  • Another object of the present invention is to provide methods of making compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker.
  • a further object of the present invention is to provide methods of preventing and treating disease in plants, including diseases caused by Xanthomonas species such as citrus canker, which include applying compositions described herein to plants.
  • the present invention provides non-toxic, naturally-derived, environmentally friendly compositions and methods for treating and preventing bacterial and fungal diseases, especially disease caused by species of the bacteria Xanthomonas such as citrus canker.
  • compositions of the present invention may comprise d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients.
  • Applicants have unexpectedly found that such compositions are capable of treating and preventing bacterial and fungal disease in plants, especially disease caused by Xanthomonas such as citrus canker.
  • such treatments do not create any perceivable concommitant negative consequences such as, for example, fruit production decreases, leaf drop or leaf wilt.
  • percentage amounts of an ingredient are by total weight of the composition in which that ingredient is included prior to any dilution of the composition with water or other diluent and/or prior to any freeze-drying process.
  • compositions of the present invention include d-limonene.
  • D-limonene is the major component of the oil extracted from citrus rind and has been used extensively as an ingredient in cleaning products.
  • D-limonene in compositions according to the present invention may comprise up to about 100% of the non-diluted product.
  • d-limonene may comprise by weight from about 0.5% to about 20.0%, in other embodiments from about 5.0% to about 15.0%, and in other embodiments from about 9.0% to about 11.0%.
  • the weight percentage of d-limonene preferably drops to less than about 50% of the composition, more preferably less than about 20%, and most preferably less than about 10%.
  • D-limonene may be present in diluted compositions in amounts as low as 0.01% by weight. D-limonene is commercially available from many sources.
  • compositions of the present invention also may include wax material, more preferably an extract of wax material.
  • the preferred wax material is beeswax.
  • the wax and/or wax extract Prior to any dilution, may comprise from about 0.005% to about 10.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.05% to about 0.5% and even more preferably about 0.1% of the composition.
  • compositions according to the present invention may include benzoic acid, salicylic acid and paraffin, and/or extracts of any of the above, alone or in various combinations, in amounts by weight totaling those given above for wax and/or wax extract alone.
  • Extracts of wax may be obtained by heating a wax and water mixture and then filtering the solution to obtain the extracts. In certain embodiments about 99% of the solids are filtered out leaving a substantially solid-free wax extract.
  • the wax and/or wax extract may be present in amounts reflecting the degree of dilution. For example, if compositions according to the present invention are diluted prior to use by the inclusion of 3 parts diluent to 1 part concentrated composition, the amount of wax or wax extract will be about 25% of its original concentration by weight.
  • Wax such as beeswax
  • benzoic acid such as beeswax
  • salicylic acid such as benzoic acid
  • paraffin are commercially available from many sources.
  • Preservative compositions of the present invention also may include emulsifiers such as soy lecithin.
  • emulsifiers such as soy lecithin.
  • surface-active properties which provide, for example, the reduction in mixing time and the maintenance of stability of dispersions.
  • Emulsifiers such as soy lecithin also provide a desirable homogenous appearance and prevent surface separation.
  • emulsifiers used in the present invention may comprise from about 0.05 to about 15%, more preferably from about 0.5 to about 10%, and more preferably from about 1 to about 5%.
  • Lecithins, particularly soy lecithins are preferred in certain embodiments of the present invention.
  • ingredients may be used, for example, in amounts described above either alone or in combination with soy lecithin.
  • canola oil and/or caprylic acid may be used as emulsifiers. After dilution, the concentration by weight of emusifiers will drop in proportion to the extent of dilution as discussed above.
  • Emulsifiers such as soy lecithin are commercially available from many sources.
  • Compositions according to the present invention also may include monohydric alcohols such as methanol, ethanol and butanol, alone or in various combinations.
  • a preferred monohydric alcohol is ethanol.
  • a preferred combination of monohydric alcohols includes ethanol and methanol.
  • Monohydric alcohols according to the present invention may be either denatured or non-denatured. Prior to dilution, monohydric alcohol may comprise from about 0.5% to about 15.0%, more preferably about 2.0 to about 12.0%, and even more preferably from about 4.0 to about 9.0% of the composition. After dilution, the concentration by weight of monohydric alcohol will drop in proportion to the extent of dilution as discussed above. Monohydric alcohols are commercially available from many sources.
  • compositions of the present invention also may include other excipients.
  • Other excipients may include potassium hydroxide, xanthan gum, and hydrochloric acid. Potassium hydroxide and hydrochloric acid may be used to control and adjust pH levels. Xanthan gum may be used to control and adjust viscosity and also provide product stability.
  • potassium hydroxide When included in compositions according to the present invention prior to dilution, potassium hydroxide may comprise from about 0.01% to about 5.0%, more preferably from about 0.05% to about 2.0%, and even more preferably from about 0.05% to about 0.5% of the composition.
  • xanthan gum When included in compositions according to the present invention, xanthan gum may comprise from about 0.01% to about 2.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.1% to about 0.5% of the composition. After dilution the concentration by weight of these excipients, if present, will drop in proportion to the extent of dilution as discussed above. All of the above-mentioned excipients are commercially available from many sources.
  • the balance of undiluted, concentrated forms of compositions according to the present invention may comprise water.
  • the water may be purified and, if so, preferably has a bacterial colony count of less than about 100 colonies per ml.
  • the water may be made alkaline by the addition of potassium hydroxide and preferably has a pH above about 10.0.
  • the preferred water hardness is less than 1 grain per gallon or less than 50 ppm.
  • water may comprise by weight from about 35% to about 99% of compositions according to the present invention.
  • extremely concentrated compositions comprising, for example, higher amounts of d-limonene and wax and/or wax extract are intended to be within the scope of the invention. As such, water may be present in amounts lower than 35%.
  • the present invention also provides methods of making the compositions described herein. Such methods can be as simple as providing concentrated forms of d-limonene in a suitable container. Methods also include combining d-limonene and water.
  • compositions according the present invention may be made by (1) adding monohydric alcohol to water and mixing; (2) heating the alcohol and water mixture; (3) adding d-limonene and mixing; (4) heating the monohydric alcohol, d-limonene and water combination; (5) adding wax and/or wax extract and mixing further; (6) heating the monohydric alcohol, d-limonene, wax and/or wax extract and water mixture; (7) optionally filtering the mixture; and (8) optionally cooling the filtrate.
  • the method of making compositions includes the steps of (1) adding potassium hydroxide to water and mixing; (2) adding monohydric alcohol (e.g., ethanol) to the water and mixing; (3) heating the potassium hydroxide, alcohol, and water mixture to about 175° F. for five minutes or less; (4) adding d-limonene to the water and mixing, while maintaining the temperature at about 175° F. for about 15 minutes (4) adding beeswax and/or beeswax extract to the water and mixing, while maintaining the temperature at about 170° F. for about 15 minutes; (5) adding xanthan gum and mixing vigorously while allowing the mixture to cool; (6) filtering the cooled mixture.
  • monohydric alcohol e.g., ethanol
  • compositions according to the present invention may include the steps of (1) mixing water, wax and/or wax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and an emulsifier, such as soy lecithin, and mixing; and (3) adding to the container a monohydric alcohol and mixing.
  • methods of making compositions according to the present invention may include the steps of (1) mixing water, beeswax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and soy lecithin and mixing; and (3) adding to the container ethanol and mixing.
  • methods of making compositions according to the present invention may include the steps of (1) mixing in a container water, beeswax extract and potassium hydroxide, wherein water is present in amounts by weight from about 35% to about 99%, wherein the beeswax extract is present in amounts by weight from about 0.005% to about 10.0%, and wherein potassium hydroxide is present in amounts by weight from about 0.01% to about 5.0%; (2) adding to the container d-limonene and soy lecithin and mixing, wherein the d-limonene is present in amounts by weight from about 0.5% to about 20.0%, and wherein soy lecithin is present in amounts by weight from about 0.05 to about 15%; and (3) adding to the container ethanol and mixing, wherein ethanol is present in amounts by weight from 0.5% to about 15.0%.
  • d-limonene may be added prior to adding monohydric alcohol or wax and/or wax extract could be added before either d-limonene or monohydric alcohol.
  • water may be heated in any heating step (if the particular method of making the composition includes heating water or water and other components) to between about 110° to about 272° F., preferably to between about 130° to about 210° F., and more preferably to between about 165° to about 180° F.
  • the liquid mixture may then be pumped through filters at a pressure sufficient to effectively collect the composition.
  • the filtering pressure may be from about 5 to about 100 psi, preferably is from about 10 to about 40 psi, and more preferably is about 30 psi.
  • the composition may be cooled before use. Preferably the composition may be cooled to at least about 95° F. Cooling may be facilitated by the use of a heat exchanger.
  • compositions according to the present invention also may be formed into a crystalline powder form to facilitate packaging, storage and use. This may be achieved, for example, by reducing the water content to about 10% of the composition, adding xanthan gum and gum arabic in roughly equal amounts, drying the composition, and then grinding to break up larger particles. Drying may be achieved by, for example, a vacuum drier, a fluidized bed drier, a low temperature roller drier, a vacuum extrusion drier or by other drying means.
  • the present invention also includes methods of using compositions which can prevent and treat bacterial and fungal diseases in plants, especially diseases caused by Xanthomonas species, such as citrus canker.
  • An effective amount of the compositions of the present invention can be applied to plants such as citrus trees.
  • an effective amount means an amount that is sufficient to prevent and reduce bacterial or fungal disease affecting plants such as citrus canker. Accordingly, an effective amount can vary depending on whether the primary purpose is prevention or treatment, and if the latter, the severity of the disease state.
  • compositions according to the present invention may be effectively applied to citrus trees in a concentration ranging from about 1% to about 80%. Preferably, the concentration will be between 10% and 50% and more preferably between 20% and 40%. To achieve such concentrations, compositions according to the present invention may be diluted with an appropriate diluent such as water. Other suitable diluents may be used instead of water, although water should be the most economical diluent. Alternatively, compositions according to the present invention may be incorporated into existing (or yet to be developed) formulations of herbicides, pesticides and fungicides, including those currently used by commercial growers. One benefit of including compositions according to the present invention into certain herbicides, pesticides and/or fungicides is that it may reduce the total amount of toxic chemicals that would otherwise be applied to plants, including citrus trees.
  • compositions according to the present invention can be sprayed onto plants that do not have any observable disease using conventional spray equipment. Likewise, these compositions can be sprayed onto diseased plants in the same manner. For use in diseased plants, the concentration of compositions according to the present invention generally will be higher than for preventative treatments.
  • compositions according to the present invention may reduce or eliminate the growth of a wide-range of disease-causing organisms in plants, including citrus trees. These compositions have been shown to be especially effective in the treatment and prevention of citrus canker caused by Xanthomonas , including Xanthomonas campestris pv. Citri , the causative agent of citrus canker.
  • compositions according to the present invention are also effective in treating and preventing bacterial and fungal infections (and/or infestations) in other types of plants.
  • diseases include (but are not limited to) diseases caused by other Xanthomonas species, diseases caused by Pseudomonas , and diseases caused by other bacteria, as well as fungal diseases and disease caused by infestation of certain insects.
  • compositions and methods according to the present invention are also effective in preventing and/or treating diseases in tomatoes, bell peppers, grapes and other plants.
  • such compositions will be effective in treating and preventing diseases of tomatoes including bacterial spot, caused by Xanthomonas campestris pv. Vesicatoria .
  • Compositions according to the present invention also will be effective in treating and preventing early blight, late blight and septoria leaf spot.
  • compositions will be effective in treating and preventing disease in bell peppers (and other peppers) such as, for example, bacterial leaf spot, cercospora leaf spot, southern blight and tobacco mosaic virus.
  • compositions according to the present invention also will be effective in treating and/or preventing diseases associated with the wine industry. Such diseases include those effecting grapes or vines caused by fungi, such as mildew and various rot conditions, diseases caused by bacteria, such as bacterial blight and Pierce's disease, grapevine yellows disease, and diseases caused by viruses. Compositions according to the present invention also will reduce the incidence of Pylloxera.
  • composition as shown in Table 1 was used to demonstrate the effectiveness of an exemplary embodiment of the present invention in treating citrus canker: TABLE 1 monohydric alcohol (ethanol) 6.65% d-limonene 10.00% beeswax extract 1.47% water 81.40 potassium hydroxide 0.16% xanthan gum 0.16%
  • compositions in accordance with Table 1 above were tested on cultures of Xanthomonas campestris pv. citrumelo obtained from the Florida Department of Plant Industry, Florida Department of Agriculture & Consumer Services, Gainesville, Fla.
  • Xanthomonas was grown via at least two transfers at 30° C. for 48 hr in Tryptic Soy broth (TSB). The final culture was centrifuged at 10,000 ⁇ g for 10 min., the cells resuspended in sterile Butterfield's phosphate buffer (BPB) to obtain 10 mL of a suspension with an approximate cell density of 1 ⁇ 10 8 CFU/mL. The final working inoculum suspension was enumerated.
  • TLB Tryptic Soy broth
  • Sample aliquots from the initial (10 ⁇ 1 ) neutralizing tubes were serially diluted in BPB and enumerated via surface plating on pre-poured plates of Tryptic Soy agar (CYSA) agar, TSA plates were incubated for 48 h at 30° C.
  • CYSA Tryptic Soy agar
  • Bacterial counts were expressed as colony forming units per ml of sample solution and converted to log 10 transforms. Log 10 mean counts were calculated for each solution time variable. The log 10 reduction and percentage reduction (versus the control sample after 30 sec.) was also calculated for each exposure time.
  • compositions according to the present invention were shown to be highly effective in reducing Xanthomonas counts.
  • the control (BPB buffer) count of Xanthomonas was 6.11, 6.04, 6.11, and 5.94 log 10 CFU/ml of solution after 30 sec., 1 min. 5 min., and 10 min., respectively.

Abstract

Non-toxic, environmentally friendly, naturally-derived and economical compositions and methods for treating and preventing bacterial or fungal disease in plants, especially disease caused by Xanthomonas species, such as citrus canker, wherein such compositions include d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol, an emulsifier and/or other ingredients are provided. Methods of making such compositions are also provided.

Description

    CROSS REFERENCE APPLICATION
  • This application is a continuation-in-part of U.S. application Ser. No. 11/093,501 filed on Mar. 30, 2005, the entire contents of which are incorporated herein by reference.
  • FIELD OF THE INVENTION
  • The present invention relates to compositions and methods for the treatment and prevention of bacterial and fungal disease in plants. Among the important diseases which can be treated and prevented by such compositions and methods is citrus canker.
  • BACKGROUND OF THE INVENTION
  • As reported by the University of Florida Plant Pathology Department, fungal and bacterial pathogens can lower yields, reduce quality, negatively affect the aesthetic and economic value and even ultimately destroy plants, crops, pre-harvest fruits, trees, vegetables and grasses. In particular, bacterial and fungal diseases in citrus plants create huge economic burdens on the citrus industry worldwide. Citrus canker alone causes severe economic consequences in the world's citrus growing regions. The bacteria which causes citrus canker, Xanthomonas campestris pv. citri, has been found in southern Asia, Japan, the Middle East, Africa, South America and now North America. Historically, citrus canker outbreaks have occurred in North America in the early 1900s and again in 1986. Fortunately, through the use of aggressive eradication techniques, the disease was eliminated in both instances. Citrus canker, however, can be reintroduced when people inadvertantly transport infected citrus fruits and seedlings into citrus growing areas in the U.S. and elsewhere. In the U.S., Florida is by far the state most at risk from citrus canker given its combination of high humidity throughout the year, seasonal hurricanes and frequent thunderstorms accompanied by high wind gusts. (See The University of Florida Plant Pathology Department Report at vvvvw.biotech.ufl.edu/PlantContainment/canker.htm.)
  • The University of Florida Extension Service reports that in 1995 citrus canker was again detected in the U.S. in citrus trees in the Miami-Dade County, Fla. area. Citrus canker then spread to the commercial groves in southwest Florida. Since 1998 more than 870,000 trees have been destroyed in conjunction with eradication programs. (See http://edis.ifas.ufl.edu/FE286)
  • Costs in managing the threat of citrus canker include capital investment for spray equipment, the lost value of affected fruit, costs associated with inspection and eradication, and costs associated with the creation of natural windbreaks and other defensive tactics. Current spraying programs include relatively expensive copper based sprays. The University of Florida Extension Service has estimated that if citrus canker became endemic in Florida, the total cost for countering endemic citrus canker, including the use of copper based sprays, could be more than $300 per acre.
  • Many types of organic molecules possess antimicrobial properties and can he used to effectively control fungal and bacterial disease in plants. For example, previous attempts to control such disease in plants includes, for example, copper-containing fungicide and streptomycin sprays. Other fungicides, herbicides and pesticides have been used as well.
  • However, many of the currently used products are toxic to humans, animals and the exposed environment which limits large scale application of such products in, for example, citrus orchards, The Environmental Protection Act was established in 1972, in part, to address concerns over the use of potentially toxic materials to control or treat diseases in crops. In 1996 Congress passed the Food Quality Protection Act requiring the Environmental Protection Agency to reassess the safety and efficacy of every existing pesticide by 2006. Concerns about pesticide residues on plants and the exposure of field workers to such residues severely limits the amounts of pesticide that can be applied and the timing of such application. These limitations decrease the potential effectiveness of commonly used pesticides to prevent and treat bacterial and fungal disease in plants in general and citrus canker in particular.
  • Accordingly, there exists a tremendous need for effective, economical and non-toxic compositions and methods for preventing and treating bacterial and fungal disease in plants. In particular there is a tremendous need for non-toxic, environmentally friendly, effective and economical compositions and methods for preventing and treating citrus canker.
  • SUMMARY OF THE INVENTION
  • The present invention provides non-toxic, environmentally friendly, effective and economical compositions and methods which prevent and treat bacterial and fungal disease in plants. More particularly, the present invention is effective in preventing and treating disease caused by the various species of the bacteria Xanthomonas, including diseases such as citrus canker. Compositions according to the present invention include d-limonene as the primary active ingredient alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients. Applicants have unexpectedly found that such compositions are capable of preventing and treating bacterial and fungal disease in plants, including citrus canker.
  • Moreover, compositions and methods according to the present invention are environmentally friendly since they do not include or involve the use of toxic chemicals or chemicals at toxic levels. Accordingly, there are minimal regulatory limitations for the use of such compositions.
  • The present invention also provides methods of making and using such compositions.
  • Accordingly, one object of the present invention is to provide compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker, comprising d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and/or other ingredients.
  • Another object of the present invention is to provide methods of making compositions for preventing and treating bacterial and fungal disease in plants, especially diseases caused by Xanthomonas species such as citrus canker.
  • A further object of the present invention is to provide methods of preventing and treating disease in plants, including diseases caused by Xanthomonas species such as citrus canker, which include applying compositions described herein to plants.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention provides non-toxic, naturally-derived, environmentally friendly compositions and methods for treating and preventing bacterial and fungal diseases, especially disease caused by species of the bacteria Xanthomonas such as citrus canker.
  • The compositions of the present invention may comprise d-limonene alone or in combination with wax and/or wax extract, monohydric alcohol and other ingredients. Applicants have unexpectedly found that such compositions are capable of treating and preventing bacterial and fungal disease in plants, especially disease caused by Xanthomonas such as citrus canker. Moreover, such treatments do not create any perceivable concommitant negative consequences such as, for example, fruit production decreases, leaf drop or leaf wilt.
  • As used herein, unless otherwise stated, percentage amounts of an ingredient are by total weight of the composition in which that ingredient is included prior to any dilution of the composition with water or other diluent and/or prior to any freeze-drying process.
  • Compositions of the present invention include d-limonene. D-limonene is the major component of the oil extracted from citrus rind and has been used extensively as an ingredient in cleaning products. D-limonene in compositions according to the present invention may comprise up to about 100% of the non-diluted product. In certain embodiments prior to dilution, d-limonene may comprise by weight from about 0.5% to about 20.0%, in other embodiments from about 5.0% to about 15.0%, and in other embodiments from about 9.0% to about 11.0%.
  • After dilution the weight percentage of d-limonene preferably drops to less than about 50% of the composition, more preferably less than about 20%, and most preferably less than about 10%. D-limonene may be present in diluted compositions in amounts as low as 0.01% by weight. D-limonene is commercially available from many sources.
  • Compositions of the present invention also may include wax material, more preferably an extract of wax material. The preferred wax material is beeswax. Prior to any dilution, the wax and/or wax extract may comprise from about 0.005% to about 10.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.05% to about 0.5% and even more preferably about 0.1% of the composition. Optionally, as a substitute for, or in addition to wax and/or wax extract, compositions according to the present invention may include benzoic acid, salicylic acid and paraffin, and/or extracts of any of the above, alone or in various combinations, in amounts by weight totaling those given above for wax and/or wax extract alone.
  • Extracts of wax may be obtained by heating a wax and water mixture and then filtering the solution to obtain the extracts. In certain embodiments about 99% of the solids are filtered out leaving a substantially solid-free wax extract.
  • After dilution, the wax and/or wax extract may be present in amounts reflecting the degree of dilution. For example, if compositions according to the present invention are diluted prior to use by the inclusion of 3 parts diluent to 1 part concentrated composition, the amount of wax or wax extract will be about 25% of its original concentration by weight.
  • Wax (such as beeswax), benzoic acid, salicylic acid and paraffin are commercially available from many sources.
  • Preservative compositions of the present invention also may include emulsifiers such as soy lecithin. Among the advantages of emulsifiers such as soy lecithin are surface-active properties which provide, for example, the reduction in mixing time and the maintenance of stability of dispersions. Emulsifiers such as soy lecithin also provide a desirable homogenous appearance and prevent surface separation. Prior to dilution, emulsifiers used in the present invention may comprise from about 0.05 to about 15%, more preferably from about 0.5 to about 10%, and more preferably from about 1 to about 5%. Lecithins, particularly soy lecithins are preferred in certain embodiments of the present invention. Other ingredients may be used, for example, in amounts described above either alone or in combination with soy lecithin. For example, canola oil and/or caprylic acid may be used as emulsifiers. After dilution, the concentration by weight of emusifiers will drop in proportion to the extent of dilution as discussed above. Emulsifiers such as soy lecithin are commercially available from many sources.
  • Compositions according to the present invention also may include monohydric alcohols such as methanol, ethanol and butanol, alone or in various combinations. A preferred monohydric alcohol is ethanol. A preferred combination of monohydric alcohols includes ethanol and methanol. Monohydric alcohols according to the present invention may be either denatured or non-denatured. Prior to dilution, monohydric alcohol may comprise from about 0.5% to about 15.0%, more preferably about 2.0 to about 12.0%, and even more preferably from about 4.0 to about 9.0% of the composition. After dilution, the concentration by weight of monohydric alcohol will drop in proportion to the extent of dilution as discussed above. Monohydric alcohols are commercially available from many sources.
  • Compositions of the present invention also may include other excipients. Other excipients may include potassium hydroxide, xanthan gum, and hydrochloric acid. Potassium hydroxide and hydrochloric acid may be used to control and adjust pH levels. Xanthan gum may be used to control and adjust viscosity and also provide product stability. When included in compositions according to the present invention prior to dilution, potassium hydroxide may comprise from about 0.01% to about 5.0%, more preferably from about 0.05% to about 2.0%, and even more preferably from about 0.05% to about 0.5% of the composition. When included in compositions according to the present invention, xanthan gum may comprise from about 0.01% to about 2.0%, preferably from about 0.01% to about 1.0%, and more preferably from about 0.1% to about 0.5% of the composition. After dilution the concentration by weight of these excipients, if present, will drop in proportion to the extent of dilution as discussed above. All of the above-mentioned excipients are commercially available from many sources.
  • The balance of undiluted, concentrated forms of compositions according to the present invention may comprise water. The water may be purified and, if so, preferably has a bacterial colony count of less than about 100 colonies per ml. The water may be made alkaline by the addition of potassium hydroxide and preferably has a pH above about 10.0. The preferred water hardness is less than 1 grain per gallon or less than 50 ppm. In certain embodiments water may comprise by weight from about 35% to about 99% of compositions according to the present invention. As discussed previously, extremely concentrated compositions comprising, for example, higher amounts of d-limonene and wax and/or wax extract are intended to be within the scope of the invention. As such, water may be present in amounts lower than 35%.
  • Methods of Making
  • The present invention also provides methods of making the compositions described herein. Such methods can be as simple as providing concentrated forms of d-limonene in a suitable container. Methods also include combining d-limonene and water.
  • In another embodiment, compositions according the present invention may be made by (1) adding monohydric alcohol to water and mixing; (2) heating the alcohol and water mixture; (3) adding d-limonene and mixing; (4) heating the monohydric alcohol, d-limonene and water combination; (5) adding wax and/or wax extract and mixing further; (6) heating the monohydric alcohol, d-limonene, wax and/or wax extract and water mixture; (7) optionally filtering the mixture; and (8) optionally cooling the filtrate.
  • In another embodiment the method of making compositions includes the steps of (1) adding potassium hydroxide to water and mixing; (2) adding monohydric alcohol (e.g., ethanol) to the water and mixing; (3) heating the potassium hydroxide, alcohol, and water mixture to about 175° F. for five minutes or less; (4) adding d-limonene to the water and mixing, while maintaining the temperature at about 175° F. for about 15 minutes (4) adding beeswax and/or beeswax extract to the water and mixing, while maintaining the temperature at about 170° F. for about 15 minutes; (5) adding xanthan gum and mixing vigorously while allowing the mixture to cool; (6) filtering the cooled mixture.
  • In another embodiment methods of making compositions according to the present invention may include the steps of (1) mixing water, wax and/or wax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and an emulsifier, such as soy lecithin, and mixing; and (3) adding to the container a monohydric alcohol and mixing.
  • In another embodiment, methods of making compositions according to the present invention may include the steps of (1) mixing water, beeswax extract, and potassium hydroxide in a container; (2) adding to the container d-limonene and soy lecithin and mixing; and (3) adding to the container ethanol and mixing.
  • In yet another embodiment, methods of making compositions according to the present invention may include the steps of (1) mixing in a container water, beeswax extract and potassium hydroxide, wherein water is present in amounts by weight from about 35% to about 99%, wherein the beeswax extract is present in amounts by weight from about 0.005% to about 10.0%, and wherein potassium hydroxide is present in amounts by weight from about 0.01% to about 5.0%; (2) adding to the container d-limonene and soy lecithin and mixing, wherein the d-limonene is present in amounts by weight from about 0.5% to about 20.0%, and wherein soy lecithin is present in amounts by weight from about 0.05 to about 15%; and (3) adding to the container ethanol and mixing, wherein ethanol is present in amounts by weight from 0.5% to about 15.0%.
  • It should be noted that the order of steps recited above in embodiments of the present invention may be varied to produce compositions according to the present invention. For example, d-limonene may be added prior to adding monohydric alcohol or wax and/or wax extract could be added before either d-limonene or monohydric alcohol.
  • In certain examples of embodiments of the present invention, water may be heated in any heating step (if the particular method of making the composition includes heating water or water and other components) to between about 110° to about 272° F., preferably to between about 130° to about 210° F., and more preferably to between about 165° to about 180° F.
  • The liquid mixture may then be pumped through filters at a pressure sufficient to effectively collect the composition. The filtering pressure may be from about 5 to about 100 psi, preferably is from about 10 to about 40 psi, and more preferably is about 30 psi. The composition may be cooled before use. Preferably the composition may be cooled to at least about 95° F. Cooling may be facilitated by the use of a heat exchanger.
  • Compositions according to the present invention also may be formed into a crystalline powder form to facilitate packaging, storage and use. This may be achieved, for example, by reducing the water content to about 10% of the composition, adding xanthan gum and gum arabic in roughly equal amounts, drying the composition, and then grinding to break up larger particles. Drying may be achieved by, for example, a vacuum drier, a fluidized bed drier, a low temperature roller drier, a vacuum extrusion drier or by other drying means.
  • Methods of Using
  • The present invention also includes methods of using compositions which can prevent and treat bacterial and fungal diseases in plants, especially diseases caused by Xanthomonas species, such as citrus canker. An effective amount of the compositions of the present invention can be applied to plants such as citrus trees. In this context an effective amount means an amount that is sufficient to prevent and reduce bacterial or fungal disease affecting plants such as citrus canker. Accordingly, an effective amount can vary depending on whether the primary purpose is prevention or treatment, and if the latter, the severity of the disease state.
  • In general, however, compositions according to the present invention may be effectively applied to citrus trees in a concentration ranging from about 1% to about 80%. Preferably, the concentration will be between 10% and 50% and more preferably between 20% and 40%. To achieve such concentrations, compositions according to the present invention may be diluted with an appropriate diluent such as water. Other suitable diluents may be used instead of water, although water should be the most economical diluent. Alternatively, compositions according to the present invention may be incorporated into existing (or yet to be developed) formulations of herbicides, pesticides and fungicides, including those currently used by commercial growers. One benefit of including compositions according to the present invention into certain herbicides, pesticides and/or fungicides is that it may reduce the total amount of toxic chemicals that would otherwise be applied to plants, including citrus trees.
  • Compositions according to the present invention can be sprayed onto plants that do not have any observable disease using conventional spray equipment. Likewise, these compositions can be sprayed onto diseased plants in the same manner. For use in diseased plants, the concentration of compositions according to the present invention generally will be higher than for preventative treatments.
  • Compositions according to the present invention may reduce or eliminate the growth of a wide-range of disease-causing organisms in plants, including citrus trees. These compositions have been shown to be especially effective in the treatment and prevention of citrus canker caused by Xanthomonas, including Xanthomonas campestris pv. Citri, the causative agent of citrus canker.
  • In addition to use in citrus species, compositions according to the present invention are also effective in treating and preventing bacterial and fungal infections (and/or infestations) in other types of plants. Such diseases include (but are not limited to) diseases caused by other Xanthomonas species, diseases caused by Pseudomonas, and diseases caused by other bacteria, as well as fungal diseases and disease caused by infestation of certain insects.
  • In addition to citrus plants, compositions and methods according to the present invention are also effective in preventing and/or treating diseases in tomatoes, bell peppers, grapes and other plants. For example, such compositions will be effective in treating and preventing diseases of tomatoes including bacterial spot, caused by Xanthomonas campestris pv. Vesicatoria. Compositions according to the present invention also will be effective in treating and preventing early blight, late blight and septoria leaf spot.
  • Similarly, such compositions will be effective in treating and preventing disease in bell peppers (and other peppers) such as, for example, bacterial leaf spot, cercospora leaf spot, southern blight and tobacco mosaic virus.
  • Compositions according to the present invention also will be effective in treating and/or preventing diseases associated with the wine industry. Such diseases include those effecting grapes or vines caused by fungi, such as mildew and various rot conditions, diseases caused by bacteria, such as bacterial blight and Pierce's disease, grapevine yellows disease, and diseases caused by viruses. Compositions according to the present invention also will reduce the incidence of Pylloxera.
  • EXAMPLE 1
  • The composition as shown in Table 1 was used to demonstrate the effectiveness of an exemplary embodiment of the present invention in treating citrus canker:
    TABLE 1
    monohydric alcohol (ethanol) 6.65%
    d-limonene 10.00%
    beeswax extract 1.47%
    water 81.40
    potassium hydroxide 0.16%
    xanthan gum 0.16%
  • Ten citrus trees with existing canker lesions were drench sprayed with a 25% solution of the composition according to Table 1, while ten citrus trees were used as controls. Tree limbs were tagged with strips of caution tape to facilitate precise identification of the treatment trees. Weekly observations were taken to determine the effect of the treatment on the canker lesions. A second treatment was applied approximately two weeks after the first. Over the course of eight weeks of observation, canker lesions had not expanded on the ten treatment trees, while canker lesions had grown substantially on the ten control trees. The treatment trees and control trees both exhibited similar insubstantial levels of leaf wilting and fruit drop.
  • EXAMPLE 2
  • In order to more precisely quantify the effectiveness of compositions according to the present invention, compositions in accordance with Table 1 above were tested on cultures of Xanthomonas campestris pv. citrumelo obtained from the Florida Department of Plant Industry, Florida Department of Agriculture & Consumer Services, Gainesville, Fla.
  • Test Procedures
  • Xanthomonas was grown via at least two transfers at 30° C. for 48 hr in Tryptic Soy broth (TSB). The final culture was centrifuged at 10,000×g for 10 min., the cells resuspended in sterile Butterfield's phosphate buffer (BPB) to obtain 10 mL of a suspension with an approximate cell density of 1×108 CFU/mL. The final working inoculum suspension was enumerated.
  • A modification of the AOAC Method 960.09 (Germicidal and Detergent Sanitizing Action of Disinfectants) was used to test the disinfectant efficacy of a solution of the composition.
      • 1) Two flasks containing 99 ml each of the antimicrobial solution were prepared in sterile 250 ml flasks containing sterile stir bars. A single flask of control solution (99 ml of sterile Butterfield's phosphate buffer (BPB) was also prepared. The flasks were equilibrated to room temperature (22-25° C.) before initiating the efficacy tests.
      • 2) One ml of the inoculum suspension (108 CFU/ml) was inoculated into each of the flasks while stirring slowly to yield a flask inoculum level of ca. 106 CFU/ml. The flasks were stirred slowly during the tests.
      • 3) Each flask was sampled 30 sec. after inoculation and subsequently after 1, 5, and 10 min. of incubation/exposure at 25° C. Flasks were sampled by aseptically transferring a one ml aliquot to a tube containing 9.0 ml of Difco neutralizing broth (to yield an initial dilution of 1:10).
        Microbial Analysis
  • Sample aliquots from the initial (10−1) neutralizing tubes were serially diluted in BPB and enumerated via surface plating on pre-poured plates of Tryptic Soy agar (CYSA) agar, TSA plates were incubated for 48 h at 30° C.
  • Bacterial counts were expressed as colony forming units per ml of sample solution and converted to log10 transforms. Log10 mean counts were calculated for each solution time variable. The log10 reduction and percentage reduction (versus the control sample after 30 sec.) was also calculated for each exposure time.
  • Results
  • Compositions according to the present invention were shown to be highly effective in reducing Xanthomonas counts. The control (BPB buffer) count of Xanthomonas was 6.11, 6.04, 6.11, and 5.94 log10 CFU/ml of solution after 30 sec., 1 min. 5 min., and 10 min., respectively. There was an increasing reduction of Xanthomonas counts in the test solution as the exposure times increased with significant reductions (i.e., >1 log10 CFU/ml) noted after 5 and 10 min. exposure times. There was a 1.98 log10 CFU/ml (98.94%) reduction of mean Xanthomonas counts in the test solution following a 5 min. exposure time and a 4.16 log10 CFU/ml (99.995%) reduction of mean Xanthomonas counts following a 10 min. exposure time.

Claims (38)

1. A composition for treating and preventing disease in plants comprising d-limonene.
2. The composition of claim 1, further comprising wax and/or wax extract.
3. The composition of claim 2, further comprising monohydric alcohol.
4. The composition of claim 3, further comprising potassium hydroxide.
5. The composition of claim 4, further comprising an emulsifier.
6. The composition of claim 5, wherein the emulsifier is soy lecithin.
7. The composition of claim 1, wherein d-limonene is present in an amount up to about 50% by weight and wherein said composition further comprises water.
8. The composition of claim 7, further comprising wax and/or wax extract.
9. The composition of claim 8, further comprising monohydric alcohol.
10. The composition of claim 9, further comprising potassium hydroxide.
11. The composition of claim 10, further comprising an emulsifier.
12. The composition of claim 11, wherein the emulsifier is soy lecithin.
13. The composition of claim 7, comprising from about 0.5% to about 20% d-limonene, from about 0.005% to about 5.0% wax and/or wax extract, from about 0.5% to about 15% monohydric alcohol, from about 0.01% to about 5.0% potassium hydroxide, and from about 0.05% to about 15% emulsifier, all by weight.
14. The composition of claim 13, wherein the monohydric alcohol is selected from the group consisting of ethanol, methanol and butanol, alone or in combination.
15. The composition of claim 13, wherein the wax and/or wax extract comprises beeswax and/or beeswax extract.
16. The composition of claim 13, wherein the emulsifier comprises soy lecithin.
17. The composition of claim 13, wherein the plant is a member of the citrus species.
18. The composition of claim 17, wherein the disease is citrus canker.
19. The composition of claim 13, wherein the disease is caused by any species of Xanthomonas.
20. A method for treating or preventing disease in a plant species comprising applying to said plant species a composition which comprises d-limonene.
21. The method of claim 20, wherein said composition further comprises wax and/or wax extract.
22. The method of claim 21, wherein said composition further comprises monohydric alcohol.
23. The method of claim 22, wherein said composition further comprises potassium hydroxide.
24. The method of claim 23, wherein said composition further comprises an emulsifier.
25. The method of claim 24, wherein the emulsifier is soy lecithin.
26. The method of claim 20, wherein d-limonene is present in an amount up to about 50% by weight and wherein said composition further comprises water.
27. The method of claim 26, wherein said composition further comprises wax and/or wax extract.
28. The method of claim 27, wherein said composition further comprises monohydric alcohol.
29. The method of claim 28, wherein said composition further comprises potassium hydroxide.
30. The method of claim 29, wherein said composition further comprises an emulsifier.
31. The method of claim 30, wherein the emulsifier is soy lecithin.
32. The method of claim 26, wherein said composition comprises from about 0.5% to about 20% d-limonene, from about 0.005% to about 5.0% wax and/or wax extract, from about 0.5% to about 15% monohydric alcohol, from about 0.01% to about 5.0% potassium hydroxide, and from about 0.05% to about 15% emulsifier, all by weight.
33. The method of claim 32, wherein the monohydric alcohol is selected from the group consisting of ethanol, methanol and butanol, alone or in combination.
34. The composition of claim 32, wherein the wax and/or wax extract comprises beeswax and/or beeswax extract.
35. The method of claim 32, wherein the emulsifier comprises soy lecithin.
36. The method of claim 32, wherein the plant is a member of the citrus species.
37. The method of claim 36, wherein the disease is citrus canker.
38. The method of claim 32, wherein the disease is caused by any species of Xanthomonas.
US11/535,737 2005-03-30 2006-09-27 Compositions and Methods for the Prevention and Treatment of Diseases in Plants Abandoned US20080021114A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/535,737 US20080021114A1 (en) 2005-03-30 2006-09-27 Compositions and Methods for the Prevention and Treatment of Diseases in Plants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/093,501 US7226610B2 (en) 2005-03-30 2005-03-30 Compositions and methods for the treatment and prevention of disease in plants
US11/535,737 US20080021114A1 (en) 2005-03-30 2006-09-27 Compositions and Methods for the Prevention and Treatment of Diseases in Plants

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/093,501 Continuation-In-Part US7226610B2 (en) 2005-03-30 2005-03-30 Compositions and methods for the treatment and prevention of disease in plants

Publications (1)

Publication Number Publication Date
US20080021114A1 true US20080021114A1 (en) 2008-01-24

Family

ID=37053718

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/093,501 Expired - Fee Related US7226610B2 (en) 2005-03-30 2005-03-30 Compositions and methods for the treatment and prevention of disease in plants
US11/535,737 Abandoned US20080021114A1 (en) 2005-03-30 2006-09-27 Compositions and Methods for the Prevention and Treatment of Diseases in Plants
US11/742,839 Abandoned US20070196409A1 (en) 2005-03-30 2007-05-01 Compositions and methods for the treatment and prevention of disease in plants

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/093,501 Expired - Fee Related US7226610B2 (en) 2005-03-30 2005-03-30 Compositions and methods for the treatment and prevention of disease in plants

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/742,839 Abandoned US20070196409A1 (en) 2005-03-30 2007-05-01 Compositions and methods for the treatment and prevention of disease in plants

Country Status (2)

Country Link
US (3) US7226610B2 (en)
WO (1) WO2006105342A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100092631A1 (en) * 2007-02-16 2010-04-15 Alberto Sardo Combinations of abietic acid esters with one or mote terpenes and use thereof for coating fruit or vegetables

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226610B2 (en) * 2005-03-30 2007-06-05 Preservation Sciences, Inc. Compositions and methods for the treatment and prevention of disease in plants
US8221791B1 (en) 2008-12-10 2012-07-17 University Of Central Florida Research Foundation, Inc. Silica-based antibacterial and antifungal nanoformulation
MX2012011104A (en) 2010-03-30 2012-11-29 Univ Central Florida Res Found Multifunctional silica-based compositions and gels, methods of making them, and methods of using them.
US9491946B2 (en) 2011-11-01 2016-11-15 University Of Central Florida Research Foundation, Inc. Ag loaded silica nanoparticle/nanogel formulation, methods of making, and methods of use
US9781936B2 (en) 2013-10-09 2017-10-10 University Of Central Florida Research Foundation, Inc. Compositions, methods of making a composition, and methods of use
US9215877B2 (en) 2014-02-05 2015-12-22 University Of Central Florida Research Foundation, Inc. Compositions including a vacancy-engineered(VE)-ZnO nanocomposite, methods of making a composition , method of using a composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462690A (en) * 1994-09-09 1995-10-31 Colgate-Palmolive Co. Liquid cleaning compositions
US5843215A (en) * 1997-04-07 1998-12-01 Warmm Sciences, Llc Insect repellent coatings
US5935272A (en) * 1999-02-02 1999-08-10 Milliken & Company Compositions comprising aryloxypolyoxyalkylene naphthalimide derivative colorants
US6482455B1 (en) * 1999-11-11 2002-11-19 Inabonos S.A. Natural source composition for the control of post-harvest pathologies and methods of application
US20040161517A1 (en) * 2003-02-14 2004-08-19 Paul Winniczuk Food and beverage preservative
US7226610B2 (en) * 2005-03-30 2007-06-05 Preservation Sciences, Inc. Compositions and methods for the treatment and prevention of disease in plants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2938028A (en) * 1956-10-15 1960-05-24 Ventura Processors Purifying and dewaxing citrus oils
US6524605B1 (en) * 1999-08-06 2003-02-25 Iowa State University Research Foundation, Inc. Biorational repellents obtained from terpenoids for use against arthropods
BR0212163A (en) * 2001-08-28 2004-12-07 Eden Reseaech Plc Composition for treatment or prevention of plant infection

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462690A (en) * 1994-09-09 1995-10-31 Colgate-Palmolive Co. Liquid cleaning compositions
US5843215A (en) * 1997-04-07 1998-12-01 Warmm Sciences, Llc Insect repellent coatings
US5935272A (en) * 1999-02-02 1999-08-10 Milliken & Company Compositions comprising aryloxypolyoxyalkylene naphthalimide derivative colorants
US6482455B1 (en) * 1999-11-11 2002-11-19 Inabonos S.A. Natural source composition for the control of post-harvest pathologies and methods of application
US20040161517A1 (en) * 2003-02-14 2004-08-19 Paul Winniczuk Food and beverage preservative
US7226610B2 (en) * 2005-03-30 2007-06-05 Preservation Sciences, Inc. Compositions and methods for the treatment and prevention of disease in plants

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100092631A1 (en) * 2007-02-16 2010-04-15 Alberto Sardo Combinations of abietic acid esters with one or mote terpenes and use thereof for coating fruit or vegetables
US8691307B2 (en) 2007-02-16 2014-04-08 Xeda International Combinations of abietic acid esters with one or more terpenes and use thereof for coating fruit or vegetables

Also Published As

Publication number Publication date
US20070196409A1 (en) 2007-08-23
US20060222674A1 (en) 2006-10-05
US7226610B2 (en) 2007-06-05
WO2006105342A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
US20080021114A1 (en) Compositions and Methods for the Prevention and Treatment of Diseases in Plants
EP2053921B1 (en) A new antifungal composition
US20090018194A1 (en) Use of antimicrobial agents derived from alliaceous plants for the prevention and control of crop diseases, post-harvest rot and as environmental disinifectant products
KR102473524B1 (en) A composition containing a mixture containing at least fludioxonil and Aureobasidium pullulans strains
US20070087978A1 (en) Method of Controlling Animal Pests
DE60205148T2 (en) Biopesticide compositions
EP2068627A1 (en) Agent for treating and/or preventing fire blight
Seydou et al. Biocontrol of Mycosphaerella fijiensis Morelet, the causal agent of Black Sigatoka of banana tree (Musa spp.) using biopesticides in Côte d’Ivoire
WO2019012541A1 (en) Microbial composition and methods of use thereof
Gómez-Gálvez et al. Suppressive and preventive activity of chemical disinfectants against sclerotia of Verticillium dahliae in water
Khaleel et al. Coating of orange fruit with nano-silver particles to minimizing harmful environmental pollution by chemical fungicide
Dal Bello et al. Postharvest control of Botrytis gray mould in tomato by antagonists and biorational compounds
KR20210082803A (en) Disinfectant to the fire blight
Youssef et al. Preliminary studies on fungal species associated with guava fruit drop disease and possible management
Walter et al. Timing of fungicide application for Botrytis cinerea control in blackcurrant (Ribes nigrum)
CN115067364B (en) High-efficiency low-toxicity low-residual-risk bio-chemical synergistic bactericidal composition and application thereof
CN116473113A (en) Tuber crop bud inhibitor and preparation method and application thereof
Yousif et al. Evaluation of salicylic acid solution on fungus Botrytis cinerea that caused strawberry gray mold
CN106106529A (en) A kind of new type water rice field compound disinfectant and application thereof
Radwan Mango grafting failure disease: associated fungi and possible control
Abdel-Mageed et al. CONTROLLING THE GREY MOLD AND WHITE ROT DISEASES ON BEAN PODS UNDER STORAGE CONDITIONS USING SOME SAFELY CHEMICAL COMPOUNDS
Shahi et al. Assessment of broad spectrum control potential of Eucalyptus citriodora oil against post harvest spoilage of Malus pumilo L
CA3126109A1 (en) A fungicidal composition comprising hibiscus leaf extract and karanj oil and uses thereof
CA3149059A1 (en) A mucilage based plant protection product and method thereof
US20170258096A1 (en) Compositions and methods to treat plant pathogens

Legal Events

Date Code Title Description
AS Assignment

Owner name: TRANSFER TECHNOLOGIES INTERNATIONAL CORPORATION, F

Free format text: PURCHASE AGREEMENT;ASSIGNOR:SB INVESTMENT TRUST;REEL/FRAME:020817/0827

Effective date: 20080402

Owner name: HYMAN, LARRY S., FLORIDA

Free format text: COURT ORDER;ASSIGNOR:PRESERVATION SCIENCES, INC.;REEL/FRAME:020817/0799

Effective date: 20080114

Owner name: SB INVESTMENT TRUST, FLORIDA

Free format text: COURT ORDER;ASSIGNOR:HYMAN, LARRY S.;REEL/FRAME:020817/0811

Effective date: 20080124

AS Assignment

Owner name: PRESERVATION SCIENCES, INC., FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELLINGER, EMERY;REEL/FRAME:020842/0919

Effective date: 20070405

AS Assignment

Owner name: PRESERVATION SCIENCES, INC., FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WINNICZUK, PAUL;REEL/FRAME:020856/0628

Effective date: 20051119

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION